Literature DB >> 22242794

Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.

Johnson Agniswamy1, Jane M Sayer, Irene T Weber, John M Louis.   

Abstract

The HIV-1 protease (PR) mediates its own release (autoprocessing) from the polyprotein precursor, Gag-Pol, flanked by the transframe region (TFR) and reverse transcriptase at its N- and C-termini, respectively. Autoprocessing at the N-terminus of PR mediates stable dimer formation essential for catalytic activity, leading to the formation of infectious virus. An antiparallel β-sheet interface formed by the four N- and C-terminal residues of each subunit is important for dimer stability. Here, we present the first high-resolution crystal structures of model protease precursor-clinical inhibitor (PI darunavir or saquinavir) complexes, revealing varying conformations of the N-terminal flanking (S(-4)FNF(-1)) and interface residues (P(1)QIT(4)). A 180° rotation of the T(4)-L(5) peptide bond is accompanied by a new Q(2)-L(5) hydrogen bond and complete disengagement of PQIT from the β-sheet dimer interface, which may be a feature for intramolecular autoprocessing. This result is consistent with drastically lower thermal stability by 14-20 °C of PI complexes of precursors and the mature PR lacking its PQIT residues (by 18.3 °C). Similar to the TFR-PR precursor, this deletion also results in a darunavir dissociation constant (2 × 10(4))-fold higher and a markedly increased dimer dissociation constant relative to the mature PR. The terminal β-sheet perturbations of the dimeric structure likely account for the drastically poorer inhibition of autoprocessing of TFR-PR relative to the mature PR, even though significant differences in active site-PI interactions in these structures were not observed. The novel conformations of the dimer interface may be exploited to target selectively the protease precursor prior to its N-terminal cleavage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22242794      PMCID: PMC3287067          DOI: 10.1021/bi201809s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  Autoprocessing of HIV-1 protease is tightly coupled to protein folding.

Authors:  J M Louis; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1999-09

2.  Mutagenesis of the dimer interface residues of tethered and untethered HIV-1 protease result in differential activity and suggest multiple mechanisms of compensation.

Authors:  Sumana Choudhury; Lori Everitt; Steven C Pettit; Andrew H Kaplan
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

Review 3.  Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules.

Authors:  Nicolas Sluis-Cremer; Gilda Tachedjian
Journal:  Eur J Biochem       Date:  2002-11

4.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 5.  Retroviral proteinases.

Authors:  S Oroszlan; R B Luftig
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

6.  Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor.

Authors:  Rieko Ishima; Dennis A Torchia; John M Louis
Journal:  J Biol Chem       Date:  2007-04-04       Impact factor: 5.157

7.  SHELXL: high-resolution refinement.

Authors:  G M Sheldrick; T R Schneider
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

8.  Kinetics and mechanism of pepsinogen activation.

Authors:  J al-Janabi; J A Hartsuck; J Tang
Journal:  J Biol Chem       Date:  1972-07-25       Impact factor: 5.157

9.  Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.

Authors:  Chun Tang; John M Louis; Annie Aniana; Jeong-Yong Suh; G Marius Clore
Journal:  Nature       Date:  2008-10-02       Impact factor: 49.962

10.  HIV-1 Protease: Structural Perspectives on Drug Resistance.

Authors:  Irene T Weber; Johnson Agniswamy
Journal:  Viruses       Date:  2009-12-03       Impact factor: 5.048

View more
  19 in total

1.  F99 is critical for dimerization and activation of South African HIV-1 subtype C protease.

Authors:  Previn Naicker; Palesa Seele; Heini W Dirr; Yasien Sayed
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

2.  C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.

Authors:  Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 3.  Highly resistant HIV-1 proteases and strategies for their inhibition.

Authors:  Irene T Weber; Daniel W Kneller; Andres Wong-Sam
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 4.  The choreography of HIV-1 proteolytic processing and virion assembly.

Authors:  Sook-Kyung Lee; Marc Potempa; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

Review 5.  Maturation of retroviruses.

Authors:  Owen Pornillos; Barbie K Ganser-Pornillos
Journal:  Curr Opin Virol       Date:  2019-06-08       Impact factor: 7.090

6.  Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.

Authors:  John M Louis; József Tözsér; Julien Roche; Krisztina Matúz; Annie Aniana; Jane M Sayer
Journal:  Biochemistry       Date:  2013-10-15       Impact factor: 3.162

7.  Understanding HIV-1 protease autoprocessing for novel therapeutic development.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

8.  Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir.

Authors:  Hironori Hayashi; Nobutoki Takamune; Takashi Nirasawa; Manabu Aoki; Yoshihiko Morishita; Debananda Das; Yasuhiro Koh; Arun K Ghosh; Shogo Misumi; Hiroaki Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution.

Authors:  Zhanglong Liu; Xi Huang; Lingna Hu; Linh Pham; Katye M Poole; Yan Tang; Brian P Mahon; Wenxing Tang; Kunhua Li; Nathan E Goldfarb; Ben M Dunn; Robert McKenna; Gail E Fanucci
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

10.  Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.

Authors:  John M Louis; Lalit Deshmukh; Jane M Sayer; Annie Aniana; G Marius Clore
Journal:  Biochemistry       Date:  2015-08-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.